In focus
Latest feed
The RNA Gamble: Avidity Biosciences Faces Its Next Big Test
The Whisper Becomes a Roar: Why Novartis Needs Avidity’s RNA Revolution, Now More Than Ever
The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition
The Big Pharma Buzz: Why Novartis Might Be Eyeing Avidity's RNA Magic
